pharmaglobenews, Author at Pharma Globenewswire

Neurofibromatosis Market in the 7MM is Expected to Witness a Major Change During the Study Period 2019–2032, Estimates DelveInsight

DelveInsight’s “Neurofibromatosis Market Insights, Epidemiology, and Market Forecast – 2032” report delivers an in-depth understanding of Neurofibromatosis, historical and forecasted epidemiology as well as the Neurofibromatosis market trends in the United States, EU5 (Germany, Spain, Italy, France, and the United Kingdom), and

13 July 2026

Uncategorised

VRDN-001 Market Set to Witness Strong Growth Driven by Phase III Success, Best-in-Class Positioning, and Expanding Thyroid Eye Disease Opportunity Through 2034

VRDN-001 Market Summary The VRDN-001 market is poised for substantial growth over the forecast period, underpinned by strong Phase III clinical results, a differentiated efficacy and safety profile, and an expanding addressable population in Thyroid Eye Disease (TED). VRDN-001 (veligrotug), developed by

10 July 2026

Uncategorised

Cannabinoid Pipeline 2026: Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight

As per DelveInsight’s assessment, globally, Cannabinoid pipeline constitutes 40+ key companies continuously working towards developing 50+ Cannabinoid treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight. “Cannabinoids Pipeline Insight, 2026“ report by DelveInsight outlines

10 July 2026

Uncategorised

Pulmonary Arterial Hypertension Pipeline Advances as 55+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

DelveInsight’s “Pulmonary Arterial Hypertension Pipeline Insight, 2026” report provides comprehensive insights about 55+ companies and 55+ pipeline drugs in the Pulmonary Arterial Hypertension pipeline landscape. It covers the Pulmonary Arterial Hypertension pipeline drug profiles, including clinical and nonclinical stage products. It also

10 July 2026

Uncategorised

Functional Dyspepsia Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

DelveInsight’s “Functional Dyspepsia Market Insights, Epidemiology, and Market Forecast – 2034” report delivers an in-depth understanding of Functional Dyspepsia, historical and forecasted epidemiology as well as the Functional Dyspepsia market trends in the United States, EU4 (Germany, France, Italy, Spain), the United

9 July 2026

Uncategorised

TEPEZZA Market Set to Witness Continued Growth Driven by Strong Commercial Uptake, Lifecycle Expansion, and Rising Demand in Thyroid Eye Disease Through 2034

TEPEZZA Market Summary The TEPEZZA market is expected to witness notable growth over the forecast period, supported by strong adoption, increasing prescriptions, and broader uptake in Thyroid Eye Disease (TED). TEPEZZA remains the first and only FDA-approved therapy specifically indicated for TED,

9 July 2026

Uncategorised

Condom Market Statistics Expected to Experience Major Growth by 2030, According to DelveInsight

DelveInsight’s “Condom Market Insights, Segmentation, and Market Forecast–2030“ provides a comprehensive analysis of the global Condom Market, including historical and forecasted Condom Market size, Condom Market share, Condom Market trends, Condom Market growth, competitive landscape, regional outlook, and future opportunities across North

8 July 2026

Uncategorised

Tracheostomy Products Market to Reach USD 310.74 Million by 2032, Driven by Rising COPD Burden and Mechanical Ventilation Demand

Tracheostomy Products Market Summary The Tracheostomy Products market was valued at USD 226.11 million in 2024 and is expected to grow at a CAGR of 4.13% during the forecast period from 2025 to 2032, reaching USD 310.74 million by 2032. Market growth

8 July 2026

Uncategorised

Advanced Ovarian Cancer Pipeline Therapeutics is anticipated to witness significant growth by 2026, estimates DelveInsight

DelveInsight’s “Advanced Ovarian Cancer Pipeline Insight, 2026” report provides comprehensive insights about 10+ companies and 12+ pipeline drugs in Advanced Ovarian Cancer pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage products, therapeutics assessment by product type, stage,

8 July 2026

Uncategorised

Antisense Oligonucleotide Therapeutics Pipeline Insight 2026: Comprehensive Analysis of 150+ Companies and 200+ Emerging Drugs Transforming RNA-Targeted Treatment

Antisense Oligonucleotide Therapeutics Pipeline Insight Summary DelveInsight’s “Antisense Oligonucleotide Therapeutics Pipeline Insight 2026” report provides comprehensive insights about 150+ companies and 200+ pipeline drugs in the Antisense Oligonucleotide Therapeutics pipeline landscape. It covers the pipeline drug profiles, including clinical and nonclinical stage

7 July 2026

pharmaglobenews

Neurofibromatosis Market in the 7MM is Expected to Witness a Major Change During the Study Period 2019–2032, Estimates DelveInsight

VRDN-001 Market Set to Witness Strong Growth Driven by Phase III Success, Best-in-Class Positioning, and Expanding Thyroid Eye Disease Opportunity Through 2034

Cannabinoid Pipeline 2026: Clinical Trials Landscape with MOA and ROA Highlights by DelveInsight

Pulmonary Arterial Hypertension Pipeline Advances as 55+ Pharma Companies Rigorously Develop Drugs for Market Entry | DelveInsight

Functional Dyspepsia Market Size in the 7MM is projected to grow at a significant CAGR by 2034, estimates DelveInsight

TEPEZZA Market Set to Witness Continued Growth Driven by Strong Commercial Uptake, Lifecycle Expansion, and Rising Demand in Thyroid Eye Disease Through 2034

Condom Market Statistics Expected to Experience Major Growth by 2030, According to DelveInsight

Tracheostomy Products Market to Reach USD 310.74 Million by 2032, Driven by Rising COPD Burden and Mechanical Ventilation Demand

Advanced Ovarian Cancer Pipeline Therapeutics is anticipated to witness significant growth by 2026, estimates DelveInsight

Antisense Oligonucleotide Therapeutics Pipeline Insight 2026: Comprehensive Analysis of 150+ Companies and 200+ Emerging Drugs Transforming RNA-Targeted Treatment

Recent Posts

Banner

Newsletter

Authors